Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet
NCT03802721Phase 1Completed
- Sponsor
- Oregon State University
- Start
- Jan 2019
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Oregon State University. Primary endpoint: Peak Plasma Concentration of 14C-BaP. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT03802721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802721.